Cargando…
Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376819/ https://www.ncbi.nlm.nih.gov/pubmed/22709909 http://dx.doi.org/10.3201/eid1807.120261 |
_version_ | 1782235876831526912 |
---|---|
author | Winston, Carla A. Mitruka, Kiren |
author_facet | Winston, Carla A. Mitruka, Kiren |
author_sort | Winston, Carla A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3376819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-33768192012-07-01 Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States Winston, Carla A. Mitruka, Kiren Emerg Infect Dis Letters to the Editor Centers for Disease Control and Prevention 2012-07 /pmc/articles/PMC3376819/ /pubmed/22709909 http://dx.doi.org/10.3201/eid1807.120261 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Letters to the Editor Winston, Carla A. Mitruka, Kiren Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title | Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title_full | Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title_fullStr | Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title_full_unstemmed | Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title_short | Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States |
title_sort | treatment duration for patients with drug-resistant tuberculosis, united states |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376819/ https://www.ncbi.nlm.nih.gov/pubmed/22709909 http://dx.doi.org/10.3201/eid1807.120261 |
work_keys_str_mv | AT winstoncarlaa treatmentdurationforpatientswithdrugresistanttuberculosisunitedstates AT mitrukakiren treatmentdurationforpatientswithdrugresistanttuberculosisunitedstates |